Li-na He
651 Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer.
Journal: Cancer communications (London, England)
Published: November 05, 2025
Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis.
Journal: Frontiers in oncology
Published: May 01, 2025
m6A2Circ: A comprehensive database for decoding the regulatory relationship between m6A modification and circular RNA.
Journal: Computational and structural biotechnology journal
Published: November 26, 2024
Tetrandrine augments melanoma cell immunogenicity via dual inhibition of autophagic flux and proteasomal activity enhancing MHC-I presentation.
Journal: Acta pharmacologica Sinica
Published: October 21, 2024
Fangchinoline-mediated autophagy inhibition amplifies antigen presentation and PD-1 blockade efficacy in lung cancer.
Journal: Acta pharmacologica Sinica
Published: October 05, 2024
Comprehensive analysis of heterogeneity and cell-cell interactions in Crohn's disease reveals novel location-specific insights.
Journal: Journal of advanced research
Published: September 15, 2024
RPS 2.0: an updated database of RNAs involved in liquid-liquid phase separation.
Journal: Nucleic acids research
Published: September 13, 2024
AStruct: detection of allele-specific RNA secondary structure in structuromic probing data.
Journal: BMC bioinformatics
Published: October 23, 2023
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.
Journal: Therapeutic advances in medical oncology
Published: February 08, 2023
Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy.
Journal: iScience
Published: January 12, 2023
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer.
Journal: Immunologic research
Published: September 13, 2022
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
Journal: Frontiers in immunology
Published: August 09, 2022
Last Updated: 09/26/2026